JEVCX
Price
$11.05
Change
-$0.00 (-0.00%)
Updated
Nov 12 closing price
VEIEX
Price
$28.92
Change
-$0.19 (-0.65%)
Updated
Nov 13 closing price
Ad is loading...

JEVCX vs VEIEX

Header iconJEVCX vs VEIEX Comparison
Open Charts JEVCX vs VEIEXBanner chart's image
JHancock Disciplined Value Em Mkts Eq C
Price$11.05
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Vanguard Emerging Mkts Stock Idx I
Price$28.92
Change-$0.19 (-0.65%)
VolumeN/A
CapitalizationN/A
JEVCX vs VEIEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JEVCX vs. VEIEX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JEVCX is a Buy and VEIEX is a Sell.

FUNDAMENTALS
Fundamentals
VEIEX has more cash in the bank: 113B vs. JEVCX (140M). VEIEX pays higher dividends than JEVCX: VEIEX (3.27) vs JEVCX (1.94). JEVCX was incepted earlier than VEIEX: JEVCX (10 years) vs VEIEX (31 years). JEVCX is a more actively managed with annual turnover of: 21.00 vs. VEIEX (5.00). VEIEX has a lower initial minimum investment than JEVCX: VEIEX (0) vs JEVCX (1000). VEIEX annual gain was more profitable for investors over the last year : 18.77 vs. JEVCX (5.06). VEIEX return over 5 years is better than : 19.04 vs. JEVCX (8.33).
JEVCXVEIEXJEVCX / VEIEX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years31 years-
Gain YTD-2.03912.262-17%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets140M113B0%
Annual Yield % from dividends1.943.2759%
Returns for 1 year5.0618.7727%
Returns for 3 years-11.52-6.06190%
Returns for 5 years8.3319.0444%
Returns for 10 years14.3827.5352%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CARA0.34N/A
N/A
Cara Therapeutics
PPL33.24-0.22
-0.66%
PPL Corp
PI194.54-4.76
-2.39%
Impinj
VNET3.48-0.10
-2.92%
VNET Group
CRBP17.94-0.65
-3.50%
Corbus Pharmaceuticals Holdings